Rhein

Rhein

SCHEMBL4417951

O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O.O=C1c2ccccc2C(=O)c2ccccc21

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 6/20 0.94
ALDH1A1 P00352 4/20 0.94
MAPT P10636 4/20 0.94
TDP1 Q9NUW8 4/20 0.94
MEN1 O00255 4/20 0.94
KMT2A Q03164 4/20 0.94
HPGD P15428 3/20 0.94
CYP3A4 P08684 3/20 0.94
RECQL P46063 3/20 0.94
TSHR P16473 3/20 0.94
POLB P06746 2/20 0.94
LMNA P02545 2/20 0.94
ALOX15 P16050 2/20 0.94
SMN1; SMN2 Q16637 2/20 0.94
HSD17B10 Q99714 2/20 0.94
KDM4E B2RXH2 2/20 0.94
FTO Q9C0B1 2/20 0.94
BCHE P06276 1/20 0.94
HSP90AA1 P07900 1/20 0.94
HSP90AB1 P08238 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rhein SCHEMBL25253 0.97 ALDH1A1 (1.00) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL29404324 0.97 ALDH1A1 (1.00) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL1356821 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL1357918 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL8012677 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL23632879 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL23632868 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL23632984 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL23633120 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1
Rhein SCHEMBL526035 0.95 ALDH1A1 (0.97) TTRALDH1A1MAPTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024037841-A1 COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF ORAL OR DENTAL DISORDERS OR DYSFUNCTIONS UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ (DE) 2024-02-22 WO disclosed
EP-4324471-A1 COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF ORAL OR DENTAL DISORDERS OR DYSFUNCTIONS Universitätsmedizin der Johannes Gutenberg-Universität Mainz (DE) 2024-02-21 EP disclosed
CN-114075158-B Method for extracting and detecting content of salvianic acid A and salvianolic acid B 西安碑林药业股份有限公司 2023-12-15 CN disclosed
EP-2872474-B1 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF UNIV GEORGIA STATE RES FOUND (US) 2022-01-19 EP disclosed
CN-112180000-B Method for detecting dampness-resolving and toxin-vanquishing composition 广东一方制药有限公司 2021-09-10 CN disclosed
US-10857112-B2 Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2020-12-08 US disclosed
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-01-28 US disclosed
US-20170239200-A1 SMALL MOLECULE INHIBITORS OF RNA BINDING MOTIF (RBM) PROTEINS FOR THE TREATMENT OF ACUTE CELLULAR INJURY University of Pittsburgh - of the Commonwealth Sys tem of Higher Education (US) 2017-08-24 US disclosed
US-9610266-B2 Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2017-04-04 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
US-6800615-B2 PARASITICIDES, NEMATOCIDES BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-10-05 US disclosed
US-20040152645-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-08-05 US disclosed
US-20040116361-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-06-17 US disclosed
US-20040106686-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-06-03 US disclosed
US-20030229032-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2003-12-11 US disclosed
WO-2003089577-A2 ANTIHELMINTHIC ANTHRAQUINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2003-10-30 WO disclosed
WO-2003089576-A2 ANTICANCER ANTHRAQUINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2003-10-30 WO disclosed
EP-0938338-A1 CARRIER COMPOSITION FOR INFLUENCING THE TIGHT JUNCTION PERMEABILITY Ghyssaert, Joris Rosa Michael (BE) 1999-09-01 EP disclosed
WO-1998005359-A1 CARRIER COMPOSITION FOR INFLUENCING THE TIGHT JUNCTION PERMEABILITY GHYSSAERT, JORIS, ROSA, MICHAEL (BE) 1998-02-12 WO disclosed
EP-0821970-A1 Carrier composition for influencing the tight junction permeability Verhaeren, Edward Henri Charles (BE) 1998-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10857112-B2 Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury RBM3, RBM12, RBM26 TTR 1148/4885ALDH1A1 4091/4885MAPT 4689/4885
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof PCNA, KRAS, RECQL TTR 4284/4885ALDH1A1 1562/4885MAPT 4878/4885
US-20170239200-A1 SMALL MOLECULE INHIBITORS OF RNA BINDING MOTIF (RBM) PROTEINS FOR THE TREATMENT OF ACUTE CELLULAR INJURY RBM3, RBM12, RBM26 TTR 1148/4885ALDH1A1 4091/4885MAPT 4689/4885
US-20030229032-A1 Antihelminthic anthraquinones and method of use thereof HRH2, HRH3, HRH1 TTR 4629/4885ALDH1A1 102/4885MAPT 4883/4885
US-20040152645-A1 Antihelminthic anthraquinones and method of use thereof HRH2, HRH3, HRH1 TTR 4629/4885ALDH1A1 102/4885MAPT 4883/4885
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof PCNA, KRAS, RECQL TTR 4284/4885ALDH1A1 1562/4885MAPT 4878/4885
US-20040106686-A1 Antihelminthic anthraquinones and method of use thereof HRH2, HRH3, HRH1 TTR 4629/4885ALDH1A1 102/4885MAPT 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.